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Background: Although endovascular therapy (EVT) has advanced, few reported the long-term outcome in terminal-aortoiliac bifurcation lesion. We 
assessed the hypothesis that EVT for terminal-aortoiliac bifurcation lesion was safe and good result.
Methods: We pooled data from patients enrolled in Real-AI (retrospective multicenter analysis for aortoiliac lesion) registry, which is a multicenter 
registry in Japan. Of 2096 patients were underwent EVT, 178 patients (Male 77%, mean follow-up 895±581days) had terminal-aortoiliac bifurcation 
lesion. The primary, assisted primary and secondary patency rates were analyzed by Kaplan-Meier Methods. Using Cox proportional-hazards model, 
factors through univariate analysis (P < 0.25) were tested in a multivariable analysis for association with primary patency rate.
Results: The primary technical success rate was achieved in 98.9% with an overall complication rate of 3.4%, and the 1 and 5 year primary 
patencies were 87% and 71%. The adjusted hazard ratio of primary patency significantly associated with female and hyperlipidemia were 2.75 (95% 
confidence interval:1.32-5.71; p<0.01) and 2.17 (95% confidence interval:1.02-5.02; p<0.05). In contrast, Trans-Atlantic Inter-Society Consensus 
(TASC)-II classification, Leriche syndrome and lesion length were not significant prognostic values.
Conclusions: In conclusion, EVT for terminal-aortoiliac bifurcation lesion was safe and acceptable regardless TASC-II classification.
